首頁 > 市場調查報告書 > 醫療設備

病患監測呼吸器

市場調查報告書

商品編碼

1618274

呼吸氣體監測儀:市場洞察·競爭環境·市場預測 (～2030年)

Respiratory Gas Monitors - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年12月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

氣喘、慢性阻塞性肺病和肺炎等呼吸系統疾病的盛行率不斷上升，推動了醫院和家庭護理機構對持續呼吸監測的需求。此外，全球外科手術的增加增加了對準確麻醉監測的需求，而呼吸氣體監測儀在追蹤氧氣和二氧化碳水平以確保患者安全方面發揮關鍵作用。由於對有效麻醉護理的需求不斷增加和技術進步，市場領導者正在推出更多產品並獲得監管部門的批准。這些具有無線連接和即時數據分析等增強功能的新設備透過滿足醫療保健提供者和患者不斷變化的需求，進一步推動了市場成長。這些因素結合在一起，預計將在 2024 年至 2030 年的預測期內推動呼吸氣體監測儀市場的發展。

呼吸氣體監測儀：市場動態

根據澳洲健康與福利研究所的最新數據，預計2022年澳洲約有850萬人（34%）患有慢性呼吸道疾病。

此外，根據《全球疾病負擔》（2023 年）的最新數據，世界上大約每 20 人中就有 1 人患有慢性呼吸道疾病。

此外，根據世界衛生組織 (2024) 提供的最新數據和統計數據，氣喘影響全球估計 2.62 億人。氣喘、慢性阻塞性肺病 (COPD) 和肺部感染等呼吸系統疾病的增加極大地推動了呼吸氣體監測儀市場的發展。隨著越來越多的患者需要持續監測氧氣、二氧化碳和其他呼吸氣體，醫院和診所正在採用先進的監測系統來提供更好的護理。這些設備可以幫助檢測呼吸窘迫的早期跡象，優化治療計劃並改善患者的治療結果。慢性呼吸道疾病的增加也增加了對醫療機構和家庭長期監測的需求，進一步增加了對便攜式、非侵入性呼吸氣體監測儀的需求。

按設備劃分，脈搏血氧計預計將在 2023 年佔據重要的市場佔有率。脈搏血氧儀為監測患者血氧飽和度 (SpO2) 和心率提供經濟高效的非侵入性解決方案，對整個呼吸氣體監測儀市場產生重大影響。醫院、門診診所和家庭護理等各種醫療機構的廣泛採用正在推動對呼吸監測解決方案的需求。脈搏血氧計的易用性和快速提供的結果使其成為醫療保健提供者的重要工具，特別是在管理慢性阻塞性肺病 (COPD) 和哮喘等呼吸系統疾病患者以及外科手術期間。

本報告提供全球呼吸氣體監測儀的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

推動市場要素
- 呼吸道疾病的發生率增加
- 世界各地的外科手術數量不斷增加。
- 麻醉監測需求不斷增加
市場限制與挑戰
- 產品召回次數增加
- 有關產品核准的嚴格監理問題
市場機會
- 將人工智慧和遠距醫療服務整合到呼吸氣體監測儀中

第6章呼吸氣體監測儀市場:波特的五力分析

第7章呼吸氣體監測儀市場評估

各設備
- 二氧化碳測量儀
- 脈動式血氧監測儀系統
- 肺計量計
- 其他
各終端用戶
- 醫院
- 診所
- 門診病人手術中心
各地區
- 北美
- 歐洲
- 亞太地區
- 其他地區

第8章呼吸氣體監測儀市場:企業·產品簡介

Medtronic plc.
Koninklijke Philips N.V.
Nihon Kohden Corporation
Dragerwerk AG & Co. KGaA
Stryker
GE Healthcare
ndd Medical Technologies
VYAIRE
Baxter
Contec
Zoll Medical Corporation
ICU Medical
Hamilton Medical
Avante Health Solutions
Nonin
BD
EDAN Instruments, Inc.
Criticare Technologies, Inc.
HILLROM
Masimo

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明·聯絡方式

簡介目錄圖表

Product Code: DIMDCL0015

Respiratory Gas Monitors Market by Device (Capnographs, Pulse Oximeters, Spirometers, and Others), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of respiratory disorders, increasing number of surgical procedures across the globe, and growing demand for anesthesia monitoring.

The global respiratory gas monitors market was valued at USD XX million in 2023, growing at a CAGR of XX% during the forecast period from 2024 to 2030 to reach USD XX million by 2030. The rising prevalence of respiratory disorders, such as asthma, COPD, and pneumonia, is driving the demand for continuous respiratory monitoring in hospitals and homecare settings. Additionally, the increasing number of surgical procedures worldwide has heightened the need for precise anesthesia monitoring, where respiratory gas monitors play a critical role in tracking oxygen and CO2 levels to ensure patient safety. The growing demand for effective anesthesia care and rising advancements in technology, leading to more product launches and regulatory approvals by key players in the market. These new devices, equipped with enhanced features like wireless connectivity and real-time data analysis, further fuel market growth by meeting the evolving needs of healthcare providers and patients globally. Together, these factors are expected to boost the market of respiratory gas monitors during the forecast period from 2024 to 2030.

Respiratory Gas Monitors Market Dynamics:

According to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions.

Additionally, as per the recent data provided by the Global Burden of Disease (2023), approximately, 1 in 20 people globally suffered from chronic respiratory diseases.

Furthermore, according to the recent data and stats provided by World Health Organization (2024), asthma affected an estimated 262 million people globally. The increase in respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), lung infections is significantly driving the market for respiratory gas monitors. With a growing number of patients requiring continuous monitoring of oxygen, carbon dioxide, and other respiratory gases, hospitals and clinics are adopting advanced monitoring systems to provide better care. These devices help detect early signs of respiratory distress, optimize treatment plans, and improve patient outcomes. The rise in chronic respiratory conditions also increases the need for long-term monitoring, both in healthcare facilities and at home, further boosting the demand for portable and non-invasive respiratory gas monitors.

According to the Global Surgery Foundation 2021 reports, about 30% of the global burden of disease is caused by conditions that can be treated by surgery. The increase in surgical procedures globally is driving the demand for respiratory gas monitors, as these devices play a vital role in patient safety during anesthesia administration. Accurate monitoring of gases like oxygen, carbon dioxide, and anesthetic agents is crucial to ensure proper ventilation and prevent complications such as hypoxia or hypercapnia. As the number of surgeries rises-particularly in areas such as cardiovascular, orthopedic, and bariatric procedures-the need for advanced anesthesia monitoring systems grows and thus the demand for respiratory gas monitors esclates. Additionally, complex surgeries often require prolonged anesthesia, making continuous respiratory monitoring essential in both operating rooms and post-anesthesia care units (PACUs). Thus, the adoption of respiratory gas monitors is further bolstered by the rise in number of surgical procedures, where real-time gas monitoring supports quicker patient recovery and discharge.

Thus, the factors mentioned above are likely to boost the market of respiratory gas monitors during the forecasted period.

However, the increased product recalls for respiratory gas monitors and stringent regulatory concerns for product approval may hinder the future market of respiratory gas monitors.

Respiratory Gas Monitors Market Segment Analysis:

In the device segment of the respiratory gas monitors market, pulse oximeters are projected to hold a considerable market share in 2023. Pulse oximeters have significantly influenced the overall market of respiratory gas monitors by providing a cost-effective, non-invasive solution for monitoring patients' oxygen saturation levels (SpO2) and heart rates. Their widespread adoption across various healthcare settings, including hospitals, outpatient clinics, and home care, has driven demand for respiratory monitoring solutions. The ease of use and rapid results offered by pulse oximeters make them an essential tool for healthcare providers, especially in the management of patients with respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and during surgical procedures.

Additionally, the increasing prevalence of respiratory illnesses, coupled with the rising emphasis on remote patient monitoring and telehealth services, has propelled the demand for pulse oximeters, leading to enhanced integration with other respiratory monitoring systems. For instance, as per the recent data provided by the World Health Organization (2023), smoking was a major cause of chronic obstructive pulmonary disease, a common lung condition that led to breathing difficulties and claimed over 3 million lives annually. Approximately 392 million people had COPD, with about 75% living in low- and middle-income countries. In high-income countries, tobacco smoking was responsible for over 70% of COPD cases. Patients with COPD often experience hypoxemia (low blood oxygen levels), necessitating continuous monitoring to ensure appropriate oxygen therapy and prevent exacerbations. Pulse oximeters provide a non-invasive, rapid, and accurate means to assess oxygen saturation levels in patients, enabling healthcare providers to make timely decisions regarding treatment adjustments.

Additionally, the increasing product approval across the globe are further propelling the market of the segment. In February 2024, Masimo announced FDA clearance of MightySat(R) Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription.

Therefore, owing to the above-mentioned factors, the pulse oximeter category is expected to generate considerable revenue thereby pushing the overall growth of the global respiratory gas monitors market during the forecast period.

North America is expected to dominate the overall respiratory gas monitors market:

Among all the regions, North America is expected to hold the largest share in the global Respiratory Gas Monitors market in 2023. The rising prevalence of respiratory disorders, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), is driving the need for effective monitoring solutions to manage these conditions. Additionally, the growing number of surgical procedures and the heightened focus on patient safety and anesthesia management further contribute to market growth. Furthermore, significant investments in research and development by leading medical device companies in North America are resulting in innovative product launches and technological advancements, enhancing the efficacy and usability of respiratory gas monitors.

According to the recent data and stats provided by American Lung Association (2024), asthma accounted for 10.8% for females and 6.5% for males across the region of United States. Additionally, as per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States. COPD, characterized by airflow limitation and respiratory symptoms, often leads to hypoxemia, requiring continuous oxygen saturation monitoring to adjust therapies appropriately. Similarly, asthma patients face variable airflow obstruction, which can lead to acute episodes, making real-time monitoring of respiratory gases essential for timely interventions. Therefore, the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD) and asthma is significantly boosting the market for respiratory gas monitors, as these conditions necessitate effective monitoring and management to ensure optimal patient outcomes.

Furthermore, the increasing number of product development activities in the region is further going to accelerate the growth of the respiratory gas monitors market. For instance, in August 2021, Roundworks Technologies Private Limited announced the approval of 510(k) for its alveoair Digital Spirometer. alveoair(R) is a personal spirometer designed for asthma, COPD, cystic fibrosis and ILD patients to help quantify their lung health.

Therefore, the factors mentioned above are expected to boost the growth of the respiratory gas monitors market in the North America region during the forecast period from 2024 to 2030.

Respiratory Gas Monitors Market Key Players:

Some of the key market players operating in the respiratory gas monitors market include Medtronic plc., Koninklijke Philips N.V., Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Stryker, GE Healthcare, ndd Medical Technologies, VYAIRE, Baxter, Contec, Zoll Medical Corporation, ICU Medical, Hamilton Medical, Avante Health Solutions, Nonin, BD, EDAN Instruments, Inc., Criticare Technologies, Inc., and HILLROM, and others.

Recent Developmental Activities in the Respiratory Gas Monitors Market:

In January, 2024, NuvoAir Medical announced that its innovative Air Next Spirometer had received formal 510(k) clearance for in-home use as a full spirometer.
In September 2022, RxCap, Inc., a cloud-based remote monitoring company, and ZEPHYRx LLC, a provider of remote respiratory monitoring solutions, announced their partnership to integrate ZEPHYRx's cloud spirometry platform with RxCap's remote monitoring platform.
In March 2022, KoKo, LLC, a software developer and medical device manufacturer and MAGNET group, a purchasing organizations (GPO) company signed a three-year partnership contract that allows access to all KoKo's "gold standard" lung function diagnostics and software for spirometry, diffusion capacity, and PFT.
In June 2021, DetelPro launched the Oxy10 pulse oximeter. This compact device has an LED display which can easily be attached to the fingertip, providing readings for oxygen saturation and pulse rate.

Key Takeaways From the Respiratory Gas Monitors Market Report Study:

Market size analysis for current respiratory gas monitors size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the respiratory gas monitors market.
Various opportunities available for the other competitors in the respiratory gas monitors market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current respiratory gas monitors market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for respiratory gas monitors market growth in the coming future?

Target Audience who can be Benefited From This Respiratory Gas Monitors Market Report Study:

Respiratory gas monitors product providers
Research organizations and consulting companies
Respiratory gas monitors-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in respiratory gas monitors
Various end-users who want to know more about the respiratory gas monitors market and the latest technological developments in the respiratory gas monitors market.

Frequently Asked Questions for the Respiratory Gas Monitors Market:

1. What are respiratory gas monitors?

Respiratory Gas Monitors are medical devices that measure oxygen and carbon dioxide levels in a patient's respiratory system, vital for ventilation and oxygenation in critical care.

2. What is the market for respiratory gas monitors?

The global respiratory gas monitors market was valued at USD XX million in 2023, growing at a CAGR of XX% during the forecast period from 2024 to 2030 to reach USD XX million by 2030.

3. What are the drivers for the respiratory gas monitors market?

The rising prevalence of respiratory disorders, such as asthma, COPD, and pneumonia, is driving the demand for continuous respiratory monitoring in hospitals and homecare settings. Additionally, the increasing number of surgical procedures worldwide has heightened the need for precise anesthesia monitoring, where respiratory gas monitors play a critical role in tracking oxygen and CO2 levels to ensure patient safety. The growing demand for effective anesthesia care aligns with advancements in technology, leading to more product launches and regulatory approvals by key players in the market. These new devices, equipped with enhanced features like wireless connectivity and real-time data analysis, further fuel market growth by meeting the evolving needs of healthcare providers and patients globally. Together, these factors are expected to boost the market of respiratory gas monitors during the forecast period from 2024 to 2030.

4. Who are the key players operating in the respiratory gas monitors market?

Some of the key market players operating in the Respiratory Gas Monitors market include Medtronic plc., Koninklijke Philips N.V., Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Stryker, GE Healthcare, ndd Medical Technologies, VYAIRE, Baxter, Contec, Zoll Medical Corporation, ICU Medical, Hamilton Medical, Avante Health Solutions, Nonin, BD, EDAN Instruments, Inc., Criticare Technologies, Inc., and HILLROM, Masimo, and others.

5. Which region has the highest share in the respiratory gas monitors market?

Among all the regions, North America is expected to hold the largest share in the global Respiratory Gas Monitors market in 2023. The rising prevalence of respiratory disorders, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), is driving the need for effective monitoring solutions to manage these conditions. Additionally, the growing number of surgical procedures and the heightened focus on patient safety and anesthesia management further contribute to market growth. Furthermore, significant investments in research and development by leading medical device companies in North America are resulting in innovative product launches and technological advancements, enhancing the efficacy and usability of respiratory gas monitors.

1. Respiratory Gas Monitors Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Respiratory Gas Monitors Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Respiratory Gas Monitors Market Key Factors Analysis

5.1. Respiratory Gas Monitors Market Drivers
- 5.1.1. Rising prevalence of respiratory disorders
- 5.1.2. Increasing number of surgical procedures across the globe
- 5.1.3. Increased demand for anesthesia monitoring
5.2. Respiratory Gas Monitors Market Restraints and Challenges
- 5.2.1. Increased product recalls
- 5.2.2. Stringent regulatory concerns for product approval
5.3. Respiratory Gas Monitors Market Opportunities
- 5.3.1. Integration of artificial intelligence and telehealth services in respiratory gas monitors

6. Respiratory Gas Monitors Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Respiratory Gas Monitors Market Assessment

7.1. By Device
- 7.1.1. Capnographs
- 7.1.2. Pulse Oximeters
- 7.1.3. Spirometers
- 7.1.4. Others
7.2. By End User
- 7.2.1. Hospitals
- 7.2.2. Clinics
- 7.2.3. Ambulatory Surgical Centers
- 7.2.4. Others
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.1.2. Canada Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.1.3. Mexico Respiratory Gas Monitors Market Size in USD Million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.2. Germany Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.3. United Kingdom Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.4. Italy Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.5. Spain Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.6. Rest of Europe Respiratory Gas Monitors Market Size in USD Million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.2. Japan Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.3. India Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.4. Australia Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.5. South Korea Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Respiratory Gas Monitors Market Size in USD Million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.4.2. Africa Respiratory Gas Monitors Market Size in USD Million (2021-2030)
  - 7.3.4.3. South America Respiratory Gas Monitors Market Size in USD Million (2021-2030)

8. Respiratory Gas Monitors Market Company and Product Profiles

8.1. Medtronic plc.
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Koninklijke Philips N.V.
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Nihon Kohden Corporation
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Dragerwerk AG & Co. KGaA
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Stryker
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. GE Healthcare
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. ndd Medical Technologies
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. VYAIRE
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Baxter
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Contec
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Zoll Medical Corporation
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. ICU Medical
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Hamilton Medical
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Avante Health Solutions
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Nonin
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. BD
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. EDAN Instruments, Inc.
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Criticare Technologies, Inc.
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. HILLROM
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Masimo
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy